{
  "content": "4.\nBeta blockers have been recommended as guideline-directed medical therapy for heart failure and after MI (S6.4.4-18, S6.4.4-19). Atrioventricular block was usually an exclusion criterion for large trials that demonstrated the benefit of beta blockers in these patient populations (S6.4.4-20—S6.4.4-22). Atrioventricular block can develop secondary to drugs such as amiodarone or sotalol that may be important for the management of AF. The benefit of any medication that exacerbates atrioventricular block must be balanced with potentially deleterious effects of right ventricular pacing (S6.4.4-23, S6.4.4-24).\n5.",
  "source": "https://www.jacc.org/doi/10.1016/j.jacc.2018.10.044",
  "chunk_id": "7e7cf94d-bf19-4abc-b837-69ba7e88e764",
  "similarity_score": 0.22111177444458008,
  "query": "beta-blockers safety profile atrial fibrillation heart failure contraindications bradycardia hypotension",
  "rank": 11,
  "title": "2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society",
  "authors": "Fred M. Kusumoto, Mark H. Schoenfeld, Coletta Barrett, James R. Edgerton, Kenneth A. Ellenbogen, Michael R. Gold, Nora F. Goldschlager, Robert M. Hamilton, José A. Joglar, Robert J. Kim, Richard Lee, Joseph E. Marine, Christopher J. McLeod, Keith R. Oken, Kristen K. Patton, Cara N. Pellegrini, Kimberly A. Selzman, Annemarie Thompson, Paul D. Varosy",
  "year": "2018",
  "journal": "JACC",
  "reference": "Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., Lee, R., Marine, J. E., McLeod, C. J., Oken, K. R., Patton, K. K., Pellegrini, C. N., Selzman, K. A., Thompson, A., & Varosy, P. D. (2018). 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. JACC, 74(7).",
  "doi": "Not available",
  "chunk_index": 398,
  "total_chunks": 1042,
  "retrieved_at": "2025-07-24T21:57:55.188511"
}